mjamilkowski
As for who - its a big universe. There are innovations in primary care, gut biome / nutrition, biometrics, physical therapy / activity, sleep, mental health, fertility / family planning, cancer, community resources / counseling, and so on. We have a running list of over 300 companies we have reviewed and have considered in terms of how to include. The hard part is to sponsor a mix that does not overlap too much. We've done that work.
As for employer-based insurance, it is the market that more than 50% of all people get their insurance from currently [1]. Is it the best way to make sure people get access to care? No, its just a convenient way to pool risk, and there are significant tax and regulatory support structures in place to prop it up. No private enterprise is going to change this and it is unreasonable to expect that outside of massive political and regulatory changes. And when that revolution happens, our technology and infrastructure will be able to continue delivering the same positive benefits to the disaggregated community because quite frankly we are agnostic to whether 50,000 people are insured by us through 250 employers or as individuals - we are still treating the issues being faced by the people in the community.
[1] KFF Data https://bit.ly/3IFQkoB
Were they able to come to consensus on anything? There was going to be winners and losers if they changed benefit plans to be on a common platform across all 3 organizations. Maybe one organization had more losers than winners.
Then Haven made the Great Vaporware Mistake with a huge public relations and marketing campaign before they actually did the hard work.
Then reality set in.
Medicare for All (MFA) is a proposal to provide the Medicare-based basic basket of medical services as a baseline for health coverage. The common assumption is the reference here is the scope of services covered by Medicare Part A and B (hospital and physician related services, respectively). This is a limited basket of services. For example, there are restrictions on how many nursing days or physical therapy sessions, and it does not cover drugs. There is no oversight in the form of quality in its current form. There are thousands of search results for the search terms “OIG” and “Medicare fraud”.
And cost - rolls eyes Funding is a political nightmare because of the need to increase taxes and likely a need to adjust physician fee schedules upwards (I.e. the inherent cost to CMS becomes higher). Most physicians look to charge commercial based business as much as 4 times what Medicare pays in order to offset what they believe to be as inadequate rates set by MedPac. That dynamic would not be sustainable in a system where Medicare was being used for everyone’s basic care needs.
We said MFA by itself may not be enough because it does not address clinical variation in care delivery or just quality of care in general, it does not address prevalence of fraud, and it does nothing to address the cost issue. We all would end up spending an extra $10,000 a year on taxes for what would likely be inadequate health benefits and still end up buying private insurance just like current seniors do with Medicare Supplemental Plans. BTW – the most popular MedSupp plans are Plan F, G and N, all of which cover the deductible of Part B and add pharmacy coverage.
Comparisons to other countries is tricky because most other countries work from an appropriations model, I.e. in United Kingdom the government sets the budget for the National Health System, and the NHS in turn sets the budget for each region, which in turn sets the budget for each hospital in that region. If you need a knee replacement inside the NHS, the hospital you live near may not have the budget to buy one or you do not meet the priority based guidelines, you will be put in queue to wait. Its not an approach we have patience for, but hopping (!?) on a plane to get one in another country is not covered. As you can see, comparing countries health systems is difficult at best, and even misleading.
Pharmacy benefit: We integrate the pharmacy benefit into the overall benefit plan. We are selling a full package, and to fully insured groups. We work with a great, NCQA/URAC accredited national pharmacy benefits manager. I think we provide pretty good pharmacy benefits (broad network, comprehensive formulary, decent prices) but it has been an interesting process to standup. Still not a lot of price transparency (even for the insurer). There is broad opportunity in this space for other players.
Sales: We are using a combined approach of direct and brokered sales efforts. As Jay responded to another question, we have been expanding our broker relationships.
Network: I am not sure I understand what you mean by two-sided network. We are building our network from scratch, which enables us to establish relationships with physicians and collaborate with them on the outcomes-based approach we prefer to use in our contracting. We use a national network to wrap around the direct contracted network so there is national coverage for emergencies. We do not believe high deductible plans and pervasive use of high copays translates into effective consumer use of healthcare services because at these levels the cost to the individual has become punitive and encourages delaying care not accessing care. incidentally, we have had a couple of self-insured employers’ express interest in our approach because even with the high deductible plan, their stop loss expenses were so high that the combination of self-insured administration fees and stop loss protection was just as expensive as being fully insured (as we offer better benefits and more care support).
There are employers and physicians that don’t see eye to eye will not want to work with us on this basis. Regardless we have built a network that satisfies all regulatory requirements. Some things will always be more expensive because of the specialization. Neonatology, for example, will always be extremely expensive for us because of the limited number of medical providers.
B2B is scalable for launch, giving us access to information and leverage that is not achievable in the individual space without significant expense and economic loss. Starting in this market segment gives us a profitable platform to expand into other coverage areas and consider adjacent market segments. That said, we believe our approach which is intensely focused on quality will drive cost savings that satisfy employers. The 3-year rate-lock option helps to demonstrate results and builds confidence in our approach without demanding changes to plan designs that may be injurious to the employee’s long-term health.
I’m not sure I completely follow your question about changing coverage to keep an employer to keep the company afloat. Our plans are approved by the state and we cannot change benefits during the year. We cannot slash benefits to reduce costs to keep a client. That would be detrimental to the employer’s business model too because it would severely impact their ability to attract and retain talent. Trying to reduce benefits would have the opposite effect and increase costs, like the delays caused by high deductibles.
There is a long way to go however because there is not a lot of trust and there are significant technology barriers. We believe our approach is a breath of fresh air.
https://pubmed.ncbi.nlm.nih.gov/31589283/
The waste usually comes down to (1) variation in clinical approaches, like a heart patient being treated differently by several different doctors, (2) administrative inefficiency, such as transposing from paper or using fax machines, and not working collaboratively, (3) abuse and fraud, like we saw in the news recently.
Here’s another one along the same lines about clinical variation
https://www.bcbs.com/the-health-of-america/reports/study-of-...